BRIEF published on 12/19/2025 at 07:35, 7 months 15 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 7 months 15 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 44ème conférence annuelle J.P. Morgan Healthcare Conference à San Francisco du 12 au 15 janvier 2026 pour présenter ses avancées en thérapies auditives Biotechnologie Conference J.P. Morgan Sensorion Thérapies Auditives
PRESS RELEASE published on 12/19/2025 at 07:30, 7 months 15 days ago Inside Information / Other news releases Sensorion to present at 44th Annual J.P. Morgan Healthcare Conference with focus on novel therapies for hearing loss disorders. CEO Nawal Ouzren to lead presentation Biotechnology Sensorion Hearing Loss Disorders J.P. Morgan Healthcare Conference Thérapies
BRIEF published on 09/17/2025 at 07:35, 10 months 16 days ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
BRIEF published on 09/17/2025 at 07:35, 10 months 16 days ago Sensorion annonce ses résultats semestriels 2025 Financement Thérapie Génique SENS-401 SENS-501 Résultats 2025
PRESS RELEASE published on 09/17/2025 at 07:30, 10 months 16 days ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
PRESS RELEASE published on 09/17/2025 at 07:30, 10 months 16 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats du premier semestre 2025, activités de thérapie génique SENS-501, GJB2-GT et SENS-401, annonce dépôts réglementaires et études cliniques en cours Résultats Thérapie Génique Études Cliniques Dépôts Réglementaires Sensorion
BRIEF published on 09/04/2025 at 07:35, 10 months 29 days ago Sensorion présentera au 60e atelier sur la biologie de l'oreille interne Biotechnologie Thérapie Génique Sensorion Perte Auditive Atelier De Biologie De L'oreille Interne
BRIEF published on 09/04/2025 at 07:35, 10 months 29 days ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
PRESS RELEASE published on 09/04/2025 at 07:30, 10 months 29 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 60ème conférence annuelle Inner Ear Biology Workshop pour présenter ses avancées en thérapie génique pour la perte auditive Thérapie Génique Sensorion Perte Auditive Biologie Oreille Interne 60ème Conférence
Published on 08/01/2026 at 01:58, 2 days 9 hours ago Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 2 days 9 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 9 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 10 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/03/2026 at 10:45, 20 minutes ago HUMAIN Makes Investment in MOZN and Partners to Co-Build Enterprise AI Solutions Locally and Globally
Published on 08/03/2026 at 10:40, 25 minutes ago ADOIT 20.0 Introduces Dynamic Search, Configurable Dashboards, and Application Compliance Assessment
Published on 08/03/2026 at 10:30, 35 minutes ago Custodian Property Income REIT plc: Total Voting Rights
Published on 08/03/2026 at 10:16, 48 minutes ago AUSTRIACARD HOLDINGS AG: Fulfilment of Condition Precedent regarding the Merger Control Clearance in relation to DNP’s Voluntary Takeover Offer
Published on 08/03/2026 at 10:58, 6 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from July 27 to July 31 2026
Published on 08/03/2026 at 10:58, 6 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 27 au 31 juillet 2026
Published on 08/03/2026 at 09:56, 1 hour 9 minutes ago Mersen : Rapport financier semestriel 2026_attestation-responsable-corrigée
Published on 08/03/2026 at 08:29, 2 hours 36 minutes ago Launch of a €225 million tranche of its share buyback programme
